{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:40:40Z","timestamp":1777578040241,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.06.010","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:47:29Z","timestamp":1654562849000},"page":"4479-4487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform"],"prefix":"10.1016","volume":"40","author":[{"given":"Jemma L","family":"Walker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Tazare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arina","family":"Tamborska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagteshwar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Donegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline E","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J","family":"Hulme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen J","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Mehrkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind M","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex J","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Davy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Inglesby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"MacKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"CA Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cockburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Hester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen JW","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick J","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian J","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Goldacre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen I","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.06.010_b0005","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Regulation 174 Information for UK healthcare professionals on COVID-19 Vaccine AstraZeneca 2020 29 December 2020]. <https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/948334\/Information_for_UK_healthcare_professionals_on_COVID-19_Vaccine_AstraZeneca.pdf>."},{"key":"10.1016\/j.vaccine.2022.06.010_b0010","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Regulation 174 Information for UK healthcare professionals on COVID-19 Vaccine Pfizer BioNTech. 2020 10 December 2020 10 December 2020]. <https:\/\/web.archive.org\/web\/20201207114708\/https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/941452\/Information_for_healthcare_professionals.pdf>."},{"key":"10.1016\/j.vaccine.2022.06.010_b0015","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Summary of Product Characteristics for COVID-19 Vaccine Moderna. 2021 19\/04\/2021 [cited 2021 30\/04\/2021]. <https:\/\/www.gov.uk\/government\/publications\/regulatory-approval-of-covid-19-vaccine-moderna\/information-for-healthcare-professionals-on-covid-19-vaccine-moderna>."},{"key":"10.1016\/j.vaccine.2022.06.010_b0020","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","author":"Patone","year":"2021","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.010_b0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.vaccine.2022.06.010_b0030","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011881","article-title":"Guillain-barre syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality","author":"Marquez Loza","year":"2021","journal-title":"Neurology"},{"issue":"32","key":"10.1016\/j.vaccine.2022.06.010_b0035","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","article-title":"Use of COVID-19 vaccines after reports of adverse events among adult recipients of janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the advisory committee on immunization practices \u2013 United States, July 2021","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.06.010_b0040","unstructured":"European Medicines Agency. COVID-19 vaccine safety update: Vaxzevria AstraZeneca AB (8 September 2021). 2021 8 September 2021 [cited 2022 11\/1\/2022]. <https:\/\/www.ema.europa.eu\/en\/documents\/covid-19-vaccine-safety-update\/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-8-september-2021_en.pdf>."},{"key":"10.1016\/j.vaccine.2022.06.010_b0045","unstructured":"UK Health Security Agency. Information for healthcare professionals on Guillain-Barr\u00e9 Syndrome (GBS) following COVID-19 vaccination 2021 17 [December 2021 11\/1\/2022]. <https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccination-guillain-barre-syndrome-information-for-healthcare-professionals\/information-for-healthcare-professionals-on-guillain-barre-syndrome-gbs-following-covid-19-vaccination>."},{"key":"10.1016\/j.vaccine.2022.06.010_b0050","doi-asserted-by":"crossref","first-page":"108818","DOI":"10.1016\/j.clim.2021.108818","article-title":"Guillain-Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine","volume":"230","author":"Garcia-Grimshaw","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2022.06.010_b0055","article-title":"Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study","author":"Shasha","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2022.06.010_b0060","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","author":"Voysey","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.010_b0065","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00415-021-10785-2","article-title":"Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature","volume":"269","author":"Khan","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.vaccine.2022.06.010_b0070","doi-asserted-by":"crossref","unstructured":"Li X, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ 2022; 376: e068373.","DOI":"10.1136\/bmj-2021-068373"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.010_b0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/pds.4173","article-title":"Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD)","volume":"26","author":"Leite","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"27","key":"10.1016\/j.vaccine.2022.06.010_b0080","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.010_b0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.010_b0090","first-page":"143","article-title":"Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination","volume":"23","author":"Shemer","year":"2021","journal-title":"Isr Med Assoc J"},{"issue":"8","key":"10.1016\/j.vaccine.2022.06.010_b0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamaoto.2021.1259","article-title":"Association of COVID-19 vaccination and facial nerve palsy: a case-control study","volume":"147","author":"Shemer","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.vaccine.2022.06.010_b0100","first-page":"965","article-title":"Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines","volume":"2","author":"McMurry","year":"2021","journal-title":"Med (N Y)"},{"key":"10.1016\/j.vaccine.2022.06.010_b0105","article-title":"Bilateral facial weakness with paraesthesia variant of Guillain-Barre syndrome following Vaxzevria COVID-19 vaccine","author":"Bonifacio","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2022.06.010_b0110","doi-asserted-by":"crossref","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2022.06.010_b0115","unstructured":"Secretary of State for Health - UK Government. Coronavirus (COVID-19): notification to organisations to share information; 2020 [October 6, 2020]. <https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-notification-of-data-controllers-to-share-information>."},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.010_b0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2022.06.010_b0125","unstructured":"Public Health England. Immunisation against Infectious Disease (the Green Book). Chapter 14a: COVID-19. (Provisional guidance subject to MHRA approval of vaccine supply)."},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.010_b0130","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2589-7500(21)00017-0","article-title":"Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study","volume":"3","author":"Mansfield","year":"2021","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.vaccine.2022.06.010_b0135","article-title":"Changes in the rate of cardiometabolic and pulmonary events during the COVID-19 pandemic","author":"Walker","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.vaccine.2022.06.010_b0140","unstructured":"NHS Improvement. The long-stays dashboard. 2019 3 July 2019 2 February 2021]. <https:\/\/improvement.nhs.uk\/resources\/long-stays-dashboard\/>."},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.010_b0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.annemergmed.2013.06.022","article-title":"Potential misdiagnoses of Bell's palsy in the emergency department","volume":"63","author":"Fahimi","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.vaccine.2022.06.010_b0150","unstructured":"Royal College of Emergency Medicine. Emergency care diagnosis simple reference set (foundation metadata concept); 2017 3 April 2017 [cited 2021 28 June 2021]. <https:\/\/dd4c.digital.nhs.uk\/dd4c\/publishedmetadatas\/intid\/710>."},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.010_b0155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.010_b0160","unstructured":"Law, B. and S.P.f.E.v. (SPEAC), SO2- D2.5.2.1 - AESI Case Definition Companion Guide for 1st Tier AESI: Facial nerve palsy. 2021."},{"key":"10.1016\/j.vaccine.2022.06.010_b0165","unstructured":"Law B. Safety Platform for Emergency vACcines (SPEAC), SO2-D2.5.2.1 -AESI Case Definition Companion Guidefor 1st Tier AESI: Acute myelitis; 2020."},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.010_b0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vaccine.2012.07.024","article-title":"Biologically plausible and evidence-based risk intervals in immunization safety research","volume":"31","author":"Rowhani-Rahbar","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.010_b0175","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/sim.7536","article-title":"Investigating the assumptions of the self-controlled case series method","volume":"37","author":"Whitaker","year":"2018","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.010_b0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/hv.2790","article-title":"Bell's palsy and parenteral inactivated influenza vaccine","volume":"2","author":"Stowe","year":"2006","journal-title":"Hum Vaccin"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.010_b0185","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:18:44Z","timestamp":1759403924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22007575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":37,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22007575"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}